Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Assessment of the Therapeutic Potential of 177Lu-PSMA Endoradiotherapy for the Treatment of Upper Metastatic Gastric Cancers Using 68Ga-PSMA PET-based Dosimetry

NCT05214820 is registered in ClinicalTrials.gov with Centre de recherche du Centre hospitalier universitaire de Sherbrooke as lead sponsor.

NCT NCT05214820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05214820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Assessment of the Therapeutic Potential of 177Lu-PSMA Endoradiotherapy for the Treatment of Upper Metastatic Gastric Cancers Using 68Ga-PSMA PET-based Dosimetry
Lead sponsor
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 17, 2022
Completion date
December 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

upper digestive tract cancer